While RET fusions occur in 1-2% of NSCLC cases, there are at least 48 unique RET fusion partners identified in NSCLC, which have been catalogued by Ou and Zhou (34), with the most common being KIF5B-RET and CCDC6-RET. The gene discussed is RET; the disease is non-small cell lung carcinoma.